Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Jun;47(6):1078-90.
doi: 10.1016/j.jpainsymman.2013.07.004. Epub 2013 Oct 5.

Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death

Andrea C Enzinger  1 , Baohui Zhang  2 , Jane C Weeks  3 , Holly G Prigerson  4
Affiliations
Multicenter Study

Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death

Andrea C Enzinger et al. J Pain Symptom Manage. 2014 Jun.

Abstract

Context: Clinical trials are a common therapeutic option for patients with advanced incurable cancer.

Objectives: To examine the associations between trial participation and end-of-life (EOL) outcomes, including aggressive care and quality of life (QOL).

Methods: Coping with Cancer, a multicenter prospective cohort study of patients with metastatic cancer, progressed after at least first-line chemotherapy. Baseline chart review documented clinical trial participation. Baseline interviews assessed psychosocial characteristics and EOL preferences. Caregiver interview and chart review assessed medical care and QOL near death. The primary outcome was aggressive EOL care (ventilation, resuscitation, or intensive care unit admission in last week of life). Propensity score weighting balanced patient characteristics that differed by trial participation, including care preferences and EOL discussion. Propensity score-weighted regression models estimated the effect of trial participation on outcomes.

Results: Of 352 patients followed to death, 37 were enrolled in a clinical trial at baseline. In propensity score-weighted analyses, trial participation was significantly associated with aggressive EOL care (21.6% vs. 12.0%, adjusted odds ratio [AOR] 2.04, 95% confidence interval [CI] 1.00-4.15), late hospice enrollment (51.4% vs. 42.2%, AOR 1.96, 95% CI 1.10-3.50), hospital death (48.6% vs. 25.7%, AOR 2.74, 95% CI 1.37-5.47), intensive care unit death (16.2% vs. 6.3%, AOR 3.53, 95% CI 1.29-9.65), and inferior QOL near death (least squares mean 5.93 vs. 7.69, P<0.001). Controlling for EOL care, trial enrollment was no longer associated with QOL near death (P=0.342).

Conclusion: Clinical trial participation is associated with aggressive EOL care. Aggressive EOL care appears to explain the association between trial participation and QOL near death.

Keywords: Palliative care; cancer; clinical trials; end-of-life care.

PubMed Disclaimer

References

    1. Nurgat ZA, Craig W, Campbell NC, et al. Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer. 2005;92:1001–1005. - PMC - PubMed
    1. National Comprehensive Cancer Network. NCCN guidelines. [Accessed May 15, 2012]; Available from http://www.nccn.org/clinical.asp.
    1. Joffe S, Weeks JC. Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst. 2002;94:1847–1853. - PubMed
    1. Peppercorn JM, Weeks JC, Cook EF, Joffe S. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet. 2004;363:263–270. - PubMed
    1. Agrawal M, Emanuel EJ. Ethics of phase 1 oncology studies: reexamining the arguments and data. JAMA. 2003;290:1075–1082. - PubMed

Publication types

LinkOut - more resources